Reuters Health Report: August 20, 2015

Click to View in Browser Thursday, August 20, 2015 'Female Viagra' seen more a pace-setter than moneymaker (Reuters) - The first U.S. treatment for low sexual desire in women, dubbed "female Viagra," is more likely to help build a market for better future rival drugs than achieve the sales seen for Pfizer Inc's famous little blue pill for men, industry experts said. Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial (Reuters) - A new diabetes pill from Eli Lilly and Co and Boehringer Ingelheim cut risk of heart attack, stroke and death in a closely watched study, the first glucose-lowering drug to show such protective results in a large cardiovascular trial, the drugmakers said on Thursday. Asian tiger mosquitoes spotted in Paris PARIS (Reuters) - Asian tiger mosquitoes, known to carry deadly diseases including dengue fever and chikungunya, were spotted in Paris for the second year running this summer, a local French health agency said. Scientists call for new review of herbicide, cite 'flawed' U.S. regulations (Reuters) - U.S. regulators have relied on flawed and outdated research to allow expanded use of an herbicide linked to cancer, and new assessments should be urgently conducted, according to a column published in the New England Journal of Medicine on Wednesday. Planned Parenthood says Florida concedes in abortion timing dispute TALLAHASSEE, Fla. (Reuters) - Planned Parenthood said on Wednesday it would drop a petition for an emergency injunction against Florida health officials, after the state backed away from what the reproductive health group had called an attempt to redefine gestation periods. Americans back federal funds for Planned Parenthood health services: poll WASHINGTON (Reuters) - Americans broadly support providing federal funding for free women's health exams, screenings and contraception services, a Reuters/Ipsos poll has found, suggesting risks for Republicans criticizing Planned Parenthood as part of the 2016 campaigns.   FDA approves 'female Viagra' with strong warning WASHINGTON/NEW YORK (Reuters) - The first drug to treat low sexual desire in women won approval from U.S. health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol. Endometrial cancer on the rise in U.S., black women most at risk (Reuters Health) - Endometrial cancer is becoming more common in the U.S. and black women appear more likely to get the most aggressive types of tumors and die from the disease, a new study suggests. First trial targeting mutation, not cancer type, gives mixed results (Reuters Health) - A powerful skin cancer drug may also be effective against lung cancer and other types of malignancies, according to a novel study that focused on a gene mutation seen in many kinds of tumors. Teens may not drink or smoke if friends are counseled not to (Reuters Health) - Teens may be less likely to drink and smoke if their friends participate in substance abuse prevention programs, a recent U.S. study suggests. Related Video Ant colony protests to save the Amazon rainforest Clean water thanks to robot swans A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2015 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook